June 22, 2024

Igor Kutyaev/iStock by way of Getty Pictures

Prime Drugs (NASDAQ:PRME) is on the forefront of gene enhancing, advancing the boundaries of genetic therapies with its progressive Prime Modifying platform. Nonetheless, the potential of this expertise is greater than only a